Grisnilimab is an IgG2a monoclonal antibody targeting CD7, implicated in tumor suppression and relevant to the pathogenesis of Wilms' tumor. This antibody functions by regulating the transcription of various target genes and may also play a role in the post-transcriptional processing of RNA. Grisnilimab is designed for research applications focusing on the molecular mechanisms of tumorigenesis and potential therapeutic interventions.
Grisnilimab is an IgG2a monoclonal antibody targeting CD7, implicated in tumor suppression and relevant to the pathogenesis of Wilms' tumor. This antibody functions by regulating the transcription of various target genes and may also play a role in the post-transcriptional processing of RNA. Grisnilimab is designed for research applications focusing on the molecular mechanisms of tumorigenesis and potential therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
